Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
NanoViricides, Inc. (NYSE Amer.: NNVC) (the "Company"), announced today that its Board of Directors has approved a 1-for-20 reverse split of all of...
NanoViricides, Inc. (NYSE Amer.: NNVC) (the "Company"), reports that it has filed its annual report (Form 10-K) for the financial year ending June...
NanoViricides, Inc. (NYSE Amer.: NNVC) (the "Company"), a leader in developing novel nanomedicines to treat viral diseases, based on the...
NanoViricides, Inc. (NYSE Amer.: NNVC) (the "Company"), a leader in developing novel nanomedicines to treat viral diseases, reports that Dr. Mark Day ...
NanoViricides, Inc. (NYSE American: NNVC) (the "Company") a company with novel platform technology to fulfill unmet medical needs in treating...
NanoViricides, Inc. (NYSE MKT: NNVC) (the "Company") a global leader in the development of highly effective antiviral therapies based on a novel...
NanoViricides, Inc. (NYSE American: NNVC) (the "Company") a company with novel platform technology to meet unmet medical needs in treating difficult...
NanoViricides, Inc. (NYSE American: NNVC) (the "Company") a company with novel platform technology to treat difficult and life-threatening viral...
NanoViricides, Inc. (NYSE MKT: NNVC) (the "Company") a company with novel platform technology to treat difficult and life-threatening viral diseases, ...
NanoViricides, Inc. (NYSE Amer.: NNVC) (the "Company"), a company with a novel platform technology to treat difficult and life-threatening viral...
NanoViricides, Inc. (NYSE Amer.: NNVC) (the "Company"), a company with novel platform technology to treat difficult and life-threatening viral...
NanoViricides, Inc. (NYSE AMER: NNVC) (the "Company"), a pioneer in developing anti-viral nanomedicine drugs, today announced it will be featured as...
NanoViricides, Inc. (NYSE Amer.: NNVC) (the "Company"), a leader in developing novel nanomedicines to treat viral diseases, reports that Mr. James...
NanoViricides, Inc. (NYSE Amer.: NNVC) (the "Company"), reports that its new CEO, Dr. Irach Taraporewala, has presented a letter to the shareholders...
NanoViricides, Inc. (NYSE Amer: NNVC) (the "Company"), a global leader in developing nanomedicines to attack pathogenic viruses, announced today that ...
NanoViricides, Inc. (NYSE Amer: NNVC) (the "Company"), a global leader in developing nanomedicines to attack viruses, announced today that it will be ...
NanoViricides, Inc. (NYSE Amer: NNVC) (the "Company") reports that its anti-Shingles drug candidates were effective in ameliorating pain sensations...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.